Sleeve Gastrectomy-Induced Weight Loss Increases Insulin Clearance in Obese Mice
International Journal of Molecular Sciences · 15.01.2023 · 24 (2) · 1729
DOI: 10.3390/ijms24021729 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.01.2023. Verfasst von Gabriela Moreira Soares und 10 weiteren Autor:innen. Beteiligte Einrichtung: Obesity and Comorbidities Research Center, Institute of Biology, University of Campinas (UNICAMP), Campinas 13083-864, Brazil. Hauptthemen laut MEDLINE: Insulin Resistance, Hyperinsulinism. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation.
Abstract (Originalsprache)
Sleeve gastrectomy (SG) successfully recovers metabolic homeostasis in obese humans and rodents while also resulting in the normalization of insulin sensitivity and insulinemia. Reduced insulin levels have been attributed to lower insulin secretion and increased insulin clearance in individuals submitted to SG. Insulin degradation mainly occurs in the liver in a process controlled, at least in part, by the insulin-degrading enzyme (IDE). However, research has yet to explore whether liver IDE expression or activity is altered after SG surgery. In this study, C57BL/6 mice were fed a chow (CTL) or high-fat diet (HFD) for 10 weeks. Afterward, the HFD mice were randomly assigned to two groups: sham-surgical (HFD-SHAM) and SG-surgical (HFD-SG). Here, we confirmed that SG improves glucose–insulin homeostasis in obese mice. Additionally, SG reduced insulinemia by reducing insulin secretion, assessed by the analysis of plasmatic C-peptide content, and increasing insulin clearance, which was evaluated through the calculation of the plasmatic C-peptide:insulin ratio. Although no changes in hepatic IDE activity were observed, IDE expression was higher in the liver of HFD-SG compared with HFD-SHAM mice. These results indicate that SG may be helpful to counteract obesity-induced hyperinsulinemia by increasing insulin clearance, likely through enhanced liver IDE expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Obesity and Comorbidities Research Center, Institute of Biology, University of Campinas (UNICAMP), Campinas 13083-864, Brazil.
- Laboratory of Endocrine Physiology and Metabolism, Biological Sciences and Health Center, Western Paraná State University (UNIOESTE), Cascavel 85819-110, Brazil.
- Center for Diabetes Research, Division of Endocrinology, Erasmus Hospital, Universite Libre de Bruxelles (ULB), 1070 Brussels, Belgium.
ORCID-Profile: Luana Emanuelly Sinhori Lopes, Carine Marmentini, Mirian Ayumi Kurauti, José Maria Costa-Júnior
Förderung
- São Paulo Research Foundation
Zitieren
APA
Soares, G. M., Lopes, L. E. S., Balbo, S. L., Marmentini, C., Bronczek, G. A., Kurauti, M. A., Bonfleur, M. L., Velloso, L. A., Carneiro, E. M., Boschero, A. C., & Costa-Júnior, J. M. (2023). Sleeve Gastrectomy-Induced Weight Loss Increases Insulin Clearance in Obese Mice. International Journal of Molecular Sciences, 24(2), 1729. https://doi.org/10.3390/ijms24021729
Vancouver
Soares GM, Lopes LES, Balbo SL, Marmentini C, Bronczek GA, Kurauti MA, et al. Sleeve Gastrectomy-Induced Weight Loss Increases Insulin Clearance in Obese Mice. International Journal of Molecular Sciences. 2023;24(2):1729. doi:10.3390/ijms24021729
BibTeX
@article{Soares2023,
author = {Soares, Gabriela Moreira and Lopes, Luana Emanuelly Sinhori and Balbo, Sandra Lucinei and Marmentini, Carine and Bronczek, Gabriela Alves and Kurauti, Mirian Ayumi and Bonfleur, Maria Lúcia and Velloso, Licio Augusto and Carneiro, Everardo Magalhães and Boschero, Antonio Carlos and Costa-Júnior, José Maria},
title = {Sleeve Gastrectomy-Induced Weight Loss Increases Insulin Clearance in Obese Mice},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {2},
pages = {1729},
doi = {10.3390/ijms24021729}
}
EUVIMED